Demonstration of ultrasound-mediated therapeutic delivery of fibrin-targeted pioglitazone-loaded echogenic liposomes into the arterial bed for attenuation of peri-stent restenosis

References

• Kee PH, Moody MR, Huang SL, et al. Stabilizing peri-stent restenosis using a novel therapeutic carrier. JACC Basic Transl Sci. 2020;5(1):1–11.
   PubMedGoogle Scholar
• Abdulhannan P, Russell DA, Homer-Vanniasinkam S. Peripheral arterial disease: a literature review. Br Med Bull. 2012;104:21–39.
   PubMed Web of Science ®Google Scholar
• Brower V. Stents and biology combination for restenosis. Nat Biotechnol. 1996;14(4):422.
   PubMed Web of Science ®Google Scholar
• Farb A, Weber DK, Kolodgie FD, et al. Morphological predictors of restenosis after coronary stenting in humans. Circulation. 2002;105(25):2974–2980.
   PubMed Web of Science ®Google Scholar
• Finn AV, Nakazawa G, Joner M, et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007;27(7):1500–1510.
   PubMed Web of Science ®Google Scholar
• Nakazawa G, Vorpahl M, Finn AV, et al. One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis. JACC Cardiovasc Imag. 2009 May;2(5):625–628.
   PubMed Web of Science ®Google Scholar
• Park SJ, Kang SJ, Virmani R, et al. In-stent neoatherosclerosis: a final common pathway of late stent failure. J Am Coll Cardiol. 2012;59(23):2051–2057.
   PubMed Web of Science ®Google Scholar
• Komiyama H, Takano M, Hata N, et al. Neoatherosclerosis: coronary stents seal atherosclerotic lesions but result in making a new problem of atherosclerosis. World J Cardiol. 2015;7(11):776–783.
   PubMedGoogle Scholar
• Otsuka F, Byrne RA, Yahagi K, et al. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J. 2015;36(32):2147–2159.
   PubMed Web of Science ®Google Scholar
• Romero ME, Yahagi K, Kolodgie FD, et al. Neoatherosclerosis from a pathologist’s point of view. Arterioscler Thromb Vasc Biol. 2015;35(10):e43–9.
   PubMed Web of Science ®Google Scholar
• Duda SH, Bosiers M, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005;16(3):331–338.
   PubMed Web of Science ®Google Scholar
• Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation. 2002;106(12):1505–1509.
   PubMed Web of Science ®Google Scholar
• Kavanaugh AF, Schulze-Koops H, Davis LS, et al. Repeat treatment of rheumatoid arthritis patients with a murine anti-intercellular adhesion molecule 1 monoclonal antibody. Arthritis Rheum. 1997;40(5):849–853.
   PubMed Web of Science ®Google Scholar
• Vuorte J, Lindsberg PJ, Kaste M, et al. Anti-ICAM-1 monoclonal antibody R6.5 (enlimomab) promotes activation of neutrophils in whole blood. J Immunol. 1999;162(4):2353–2357.
   PubMed Web of Science ®Google Scholar
• Zabczyk M, Natorska J, Undas A. Fibrin clot properties in atherosclerotic vascular disease: from pathophysiology to clinical outcomes. J Clin Med. 2021;10(13):2999.
   Web of Science ®Google Scholar
• Aruva MR, Daviau J, Sharma SS, et al. Imaging thromboembolism with fibrin-avid 99mTc-peptide: evaluation in swine. J Nucl Med. 2006;47(1):155–162.
   PubMed Web of Science ®Google Scholar
• Laudano AP, Doolittle RF. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. Proc Natl Acad Sci U S A. 1978;75(7):3085–3089.
   PubMed Web of Science ®Google Scholar
• Badimon L, Vilahur G. Thrombosis formation on atherosclerotic lesions and plaque rupture. J Intern Med. 2014;276(6):618–632.
   PubMed Web of Science ®Google Scholar
• Smith EB. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis. Clin Haematol. 1986;15(2):355–370.
   PubMedGoogle Scholar
• Scopes RK. Protein purification: Principles and practice. New York: Springer; 1982. p. 265–266.
   Google Scholar
• Klegerman ME, Huang S, Parikh D, et al. Lipid contribution to the affinity of antigen association with specific antibodies conjugated to liposomes. Biochim Biophys Acta. 2007;1768(7):1703–1716.
   PubMed Web of Science ®Google Scholar
• Klegerman ME, Hamilton AJ, Huang SL, et al. Quantitative immunoblot assay for assessment of liposomal antibody conjugation efficiency. Anal Biochem. 2002;300(1):46–52.
   PubMed Web of Science ®Google Scholar
• Abràmoff MD, Magalhães PJ, Ram SJ. Image processing with. ImageJ. Iophoton Int. 2004;11(7):36–42.
   Google Scholar
• Ansari N, Muller S, Stelzer EH, et al. Quantitative 3D cell-based assay performed with cellular spheroids and fluorescence microscopy. Methods Cell Biol. 2013;113:295–309.
   PubMed Web of Science ®Google Scholar
• Gavet O, Pines J. Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Dev Cell. 2010;18(4):533–543.
   PubMed Web of Science ®Google Scholar
• Rezaei-Darzi E, Kasza J, Forbes A, et al. Use of information criteria for selecting a correlation structure for longitudinal cluster randomised trials. Clin Trials. 2022;19(3):316–325.
   PubMed Web of Science ®Google Scholar
• Westgate PM. Improving the correlation structure selection approach for generalized estimating equations and balanced longitudinal data. Stat Med. 2014;33(13):2222–2237.
   PubMed Web of Science ®Google Scholar
• Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121–130.
   PubMed Web of Science ®Google Scholar
• Yahagi K, Kolodgie FD, Otsuka F, et al. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nat Rev Cardiol. 2016;13(2):79–98.
   PubMed Web of Science ®Google Scholar
• Staels B. PPARgamma and atherosclerosis. Curr Med Res Opin. 2005;21(sup1):S13–S20.
   PubMed Web of Science ®Google Scholar
• Ishibashi M, Egashira K, Hiasa K, et al. Antiinflammatory and antiarteriosclerotic effects of pioglitazone. Hypertension. 2002;40(5):687–693.
   PubMed Web of Science ®Google Scholar
• Lutgens E, van Suylen RJ, Faber BC, et al. Atherosclerotic plaque rupture: local or systemic process? Arterioscler Thromb Vasc Biol. 2003;23(12):2123–2130.
   PubMed Web of Science ®Google Scholar
• Kee PH, Kim H, Huang S, et al. Nitric oxide pretreatment enhances atheroma component highlighting in vivo with intercellular adhesion molecule-1-targeted echogenic liposomes. Ultrasound Med Biol. 2014;40(6):1167–1176.
   PubMed Web of Science ®Google Scholar
• Kim H, Kee PH, Rim Y, et al. Nitric oxide improves molecular imaging of inflammatory atheroma using targeted echogenic immunoliposomes. Atherosclerosis. 2013;231(2):252–260.
   PubMed Web of Science ®Google Scholar
• McCarthy JR, Patel P, Botnaru I, et al. Multimodal nanoagents for the detection of intravascular thrombi. Bioconjug Chem. 2009;20(6):1251–1255.
   PubMed Web of Science ®Google Scholar
• Buchanan KD, Huang SL, Kim H, et al. Encapsulation of NF-kappaB decoy oligonucleotides within echogenic liposomes and ultrasound-triggered release. J Control Release. 2010;141(2):193–198.
   PubMed Web of Science ®Google Scholar
• Beckman J, Raji A, Plutzky J. Peroxisome proliferator activated receptor gamma and its activation in the treatment of insulin resistance and atherosclerosis: issues and opportunities. Curr Opin Cardiol. 2003;18(6):479–485.
   PubMed Web of Science ®Google Scholar
• Li AC, Brown KK, Silvestre MJ, et al. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest. 2000;106(4):523–531.
   PubMed Web of Science ®Google Scholar
• Plutzky J. Medicine. PPARs as therapeutic targets: reverse cardiology? Science. 2003;302(5644):406–407.
   PubMed Web of Science ®Google Scholar
• Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 2007;356(24):2457–2471.
   PubMed Web of Science ®Google Scholar
• Zinn A, Felson S, Fisher E, et al. Reassessing the cardiovascular risks and benefits of thiazolidinediones. Clin Cardiol. 2008;31(9):397–403.
   PubMed Web of Science ®Google Scholar
• Moody MR, Huang S, Kim H, et al. Bioactive gas/drug co-encapsulation and release improves attenuation of intimal hyperplasia following acute arterial injury. Circulation. 2008;118(18):S573.
   Web of Science ®Google Scholar
• Herbst SM, Klegerman ME, Kim H, et al. Delivery of stem cells to porcine arterial wall with echogenic liposomes conjugated to antibodies against CD34 and intercellular adhesion molecule-1. Mol Pharm. 2010;7(1):3–11.
   PubMedGoogle Scholar
• Hitchcock KE, Caudell DN, Sutton JT, et al. Ultrasound-enhanced delivery of targeted echogenic liposomes in a novel ex vivo mouse aorta model. J Control Release. 2010;144(3):288–295.
   PubMed Web of Science ®Google Scholar
• Laing ST, Kim H, Kopechek JA, et al. Ultrasound-mediated delivery of echogenic immunoliposomes to porcine vascular smooth muscle cells in vivo. J Liposome Res. 2010;20(2):160–167.
   PubMed Web of Science ®Google Scholar
• Sutton JT, Haworth KJ, Shanmukhappa SK, et al. Delivery of bevacizumab to atheromatous porcine carotid tissue using echogenic liposomes. Drug Deliv. 2016;23(9):3594–3605.
   PubMed Web of Science ®Google Scholar
• Kim H, Kee PH, Rim Y, et al. Nitric Oxide-Enhanced molecular imaging of atheroma using vascular cellular adhesion molecule 1-targeted echogenic immunoliposomes. Ultrasound Med Biol. 2015;41(6):1701–1710.
   PubMed Web of Science ®Google Scholar
• Kim H, Moody MR, Laing ST, et al. In vivo volumetric intravascular ultrasound visualization of early/inflammatory arterial atheroma using targeted echogenic immunoliposomes. Invest Radiol. 2010;45(10):685–691.
   PubMed Web of Science ®Google Scholar
• Sutton JT, Haworth KJ, Pyne-Geithman G, et al. Ultrasound-mediated drug delivery for cardiovascular disease. Expert Opin Drug Deliv. 2013;10(5):573–592.
   PubMed Web of Science ®Google Scholar
• Kooiman K, Roovers S, Langeveld SAG, et al. Ultrasound-Responsive cavitation nuclei for therapy and drug delivery. Ultrasound Med Biol. 2020;46(6):1296–1325.
   PubMed Web of Science ®Google Scholar
• Shekhar H, Kleven RT, Peng T, et al. In vitro characterization of sonothrombolysis and echocontrast agents to treat ischemic stroke. Sci Rep. 2019;9(1):9902.
   PubMedGoogle Scholar
• Tsutsui JM, Xie F, Porter RT. The use of microbubbles to target drug delivery. Cardiovasc Ultrasound. 2004;2:23.
   PubMedGoogle Scholar
• Chowdhury SM, Abou-Elkacem L, Lee T, et al. Ultrasound and microbubble mediated therapeutic delivery: Underlying mechanisms and future outlook. J Control Release. 2020;326:75–90.
   PubMed Web of Science ®Google Scholar
• Sutton JT, Raymond JL, Verleye MC, et al. Pulsed ultrasound enhances the delivery of nitric oxide from bubble liposomes to ex vivo porcine carotid tissue. Int J Nanomedicine. 2014;9:4671–4683.
   PubMed Web of Science ®Google Scholar